Authors:
Fraher, LJ
Avram, R
Watson, PH
Hendy, GN
Henderson, JE
Chong, KL
Goltzman, D
Morley, P
Willick, GE
Whitfield, JF
Hodsman, AB
Citation: Lj. Fraher et al., Comparison of the biochemical responses to human parathyroid hormone-(1-31)NH2 and hPTH-(1-34) in healthy humans, J CLIN END, 84(8), 1999, pp. 2739-2743
Authors:
Leygue, E
Dotzlaw, H
Watson, PH
Murphy, LC
Citation: E. Leygue et al., Expression of estrogen receptor beta 1, beta 2, and beta 5 messenger RNAs in human breast tissue, CANCER RES, 59(6), 1999, pp. 1175-1179
Authors:
Dotzlaw, H
Leygue, E
Watson, PH
Murphy, LC
Citation: H. Dotzlaw et al., Estrogen receptor-beta messenger RNA expression in human breast tumor biopsies: Relationship to steroid receptor status and regulation by progestins, CANCER RES, 59(3), 1999, pp. 529-532
Authors:
Clark, JW
Snell, L
Shiu, RPC
Orr, FW
Maitre, N
Vary, CPH
Cole, DJ
Watson, PH
Citation: Jw. Clark et al., The potential role far prolactin-inducible protein (PIP) as a marker of human breast cancer micrometastasis, BR J CANC, 81(6), 1999, pp. 1002-1008
Authors:
Leygue, E
Dotzlaw, H
Watson, PH
Murphy, LC
Citation: E. Leygue et al., Altered expression of exon 6 deleted progesterone receptor variant mRNA between normal human breast and breast tumour tissues, BR J CANC, 80(3-4), 1999, pp. 379-382
Authors:
Leygue, E
Hall, RE
Dotzlaw, H
Watson, PH
Murphy, LC
Citation: E. Leygue et al., Oestrogen receptor-alpha variant mRNA expression in primary human breast tumours and matched lymph node metastases, BR J CANC, 79(5-6), 1999, pp. 978-983